Search - tctmd.com

Displaying 701 - 720 of 1363

Sort: Relevancy | Date

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

L.A. McKeown

September 10, 2020

News Daily News

CV Risk Factors Make Even Younger COVID-19 Patients More Vulnerable

L.A. McKeown

September 09, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Caitlin E. Cox

August 31, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Daily News

Bisphenol A Exposure Linked With Higher Mortality

Michael O'Riordan

August 19, 2020

News Daily News

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

Shelley Wood

August 19, 2020

News Daily News

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

Shelley Wood

August 14, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Michael O'Riordan

August 07, 2020

News Featured Fellow

Anum Minhas, MD

Yael L. Maxwell

August 07, 2020

Advertisement

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Hostility After ACS Linked to All-Cause Mortality

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Renal Function Gains Seen in CKD Patients After TAVR

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

CV Risk Factors Make Even Younger COVID-19 Patients More Vulnerable

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Dapagliflozin Wins in Patients With CKD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Influenza and Acute CV Events Can Go Hand in Hand

Bisphenol A Exposure Linked With Higher Mortality

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Anum Minhas, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content